Utrecht, Netherlands

Petrus J A Haas


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Petrus J A Haas: A Trailblazer in Biochemistry

Introduction: Petrus J A Haas, based in Utrecht, NL, is an accomplished inventor with a focus on the field of biochemistry. With a notable patent to his name, Haas has contributed significantly to the understanding and application of polypeptides, particularly those with therapeutic potential.

Latest Patents: Petrus J A Haas holds a patent titled "Polypeptides and use thereof." This invention revolves around a polypeptide that exhibits the biological activity of the Chemotaxis Inhibitory Protein, abbreviated as 'CHIPS'. The polypeptide comprises variants of the amino acid sequence found in SEQ ID NO:1. Notably, modifications can occur in several amino acids, including N31, S32, G33, and more. An essential aspect of this invention is that the polypeptide is designed to be less immunogenic in humans compared to the wildtype CHIPS protein, offering potential advantages in medical applications. Additionally, the patent details methods for producing and utilizing such variant CHIPS polypeptides, broadening their applicability in therapeutic settings.

Career Highlights: Throughout his career, Petrus J A Haas has been associated with Alligator Bioscience AB, a notable company in the biopharmaceutical sector. His work there emphasizes innovative research and the development of breakthrough therapies, enhancing the understanding of polypeptide functionality and applications.

Collaborations: In his professional journey, Haas has collaborated with esteemed colleagues such as Christina Furebring and Johannes A G Van Strijp. These collaborations have enabled the pooling of expertise and resources, driving forward the frontiers of research in polypeptides and biotechnology.

Conclusion: Petrus J A Haas is a remarkable inventor whose dedication to advancing biochemistry is evident through his innovative work and patent contributions. His continued research and collaborations are likely to yield significant developments in the field, potentially leading to new therapeutic solutions that harness the power of engineered polypeptides.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…